<DOC>
	<DOC>NCT00871806</DOC>
	<brief_summary>The study will evaluate whether the blood concentrations of eletriptan administered using two test formulations of oral disintegrating tablets are comparable to those observed with the standard commercial tablet.</brief_summary>
	<brief_title>Pharmacokinetics of Two Eletriptan Oral Formulations Given With and Without Water and the Commercial Tablet Formulation Given With Water</brief_title>
	<detailed_description />
	<mesh_term>Eletriptan</mesh_term>
	<criteria>Healthy subjects No CYP3A4 inhibitors Clinically significant disease in any organ system Positive urine drug screen</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>eletriptan</keyword>
	<keyword>bioavailability</keyword>
	<keyword>oral disintegrating tablet</keyword>
</DOC>